🇺🇸 FDA
Pipeline program

Midazolam

YP39364

Phase 1 small_molecule completed

Quick answer

Midazolam for Hepatitis B, Chronic is a Phase 1 program (small_molecule) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).

Program details

Company
Hoffmann-La Roche
Indication
Hepatitis B, Chronic
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials